(Press-News.org) A study published in Cell Stem Cell reveals that some mutations in blood stem cells might help protect against late-onset Alzheimer’s disease.
A team led by researchers at Baylor College of Medicine discovered that both a mouse model and people carrying blood stem cells with mutations in the gene TET2, but not in the gene DNMT3A, had a lower risk for developing Alzheimer’s disease. Their study proposes a mechanism that can protect against the disease and opens new avenues for potential strategies to control the emergence and progression of this devastating condition.
“Our lab has long been studying blood stem cells, also called hematopoietic stem cells,” said lead author Dr. Katherine King, professor of pediatrics – infectious diseases and a member of the Center for Cell and Gene Therapy and the Dan L Duncan Comprehensive Cancer Center at Baylor. She also is part of Texas Children’s Hospital.
Hematopoietic stem cells live in the bone marrow and generate all the different types of blood cells the body needs to stay alive and healthy – red blood cells, immune cells and platelets. As people get older, blood stem cells can develop mutations, and this occurs in about 20% of 70-year-olds. Most of the time, these mutations don’t cause problems, but sometimes, a mutation drives the cells to divide more than others, forming a clone. This process is called clonal hematopoiesis and it has been linked to a higher risk for conditions such as cardiovascular disease, stroke, blood cancers like leukemia and chronic obstructive pulmonary disease. However, many questions remain regarding the connection between clonal hematopoiesis and Alzheimer’s disease.
“In the current study, we investigated the effect of the two genes most commonly mutated in clonal hematopoiesis, TET2 and DNMT3A, on Alzheimer’s disease,” said first author Dr. Katie A. Matatall, instructor in the King lab. “We also selected these mutations because they are involved in inflammation, which is known to be increased in Alzheimer’s disease.”
The researchers assessed the effect of clonal hematopoiesis on the prevalence of Alzheimer’s disease using human data stored in the UK Biobank. They also evaluated the role of mutations in genes Tet2 and Dnmt3a in a mouse model of Alzheimer’s disease.
The team discovered that the two mutations do not behave the same way. Clonal hematopoiesis with the TET2-mutant was associated with a 47% reduced risk of late-onset Alzheimer’s disease in humans, whereas other mutations of clonal hematopoiesis did not confer protection. In a mouse model, transplantation of Tet2-mutant bone marrow reduced cognitive decline and beta-amyloid plaque formation, effects not observed with Dnmt3a-mutant cells.
“Furthermore, we found that the protective effect seemed to be mediated by TET2-clonal stem cells circulating in the blood,” Matatall said. “Immune cells derived from these clones were able to migrate into the brain where they cleared beta-amyloid deposits, a hallmark of Alzheimer’s disease, more effectively than cells without the TET2 mutation. We think that it’s both the increased migration into the brain and the enhanced ability to clear Alzheimer’s-associated damage that drives the better outcomes.”
“Until now clonal hematopoiesis has primarily been associated with promoting the progression of disease. This is the first time that these two mutations in blood stem cells have been shown to influence disease in different ways,” King said. “The findings show that some clonal hematopoiesis promote disease while others, like TET2, may provide protection. We need to think about clonal hematopoiesis in a mutation-specific way and assess their risks and benefits.”
The findings establish a novel experimental platform for understanding the role of clonal hematopoiesis in Alzheimer’s disease and may inform future approaches to mitigate the risks of central nervous system degenerative diseases.
For a complete list of the authors, their affiliations and financial sources for this work, see the publication.
###
END
Changes in the blood could protect against Alzheimer’s disease
2025-07-02
ELSE PRESS RELEASES FROM THIS DATE:
New tool allows researchers to track assembly of cells’ protein-making machines
2025-07-02
Proteins are the infinitely varied chemicals that make cells work, and science has a pretty good idea how they are made. But a critical aspect underlying the machinery of protein manufacture has long been hidden inside a blobby cellular structure called the nucleolus.
Now, a team of Princeton engineers have developed a technique to peer inside the nucleolus and reveal this hidden system of creation. Previous methods required researchers to break open the cell and destroy most of its structures, resulting in minimal access to the blob’s inner workings. By tracking the movement of RNA molecules inside the nucleolus using advanced imaging and genomics techniques, ...
New genetic marker linked to improved survival with immunotherapy in ovarian and other cancers
2025-07-02
Ovarian clear cell carcinoma is difficult to treat, and treatment options are limited
Patients with specific PPP2R1A mutations in their tumors survived significantly longer after immunotherapy treatment
Targeting PPP2R1A may improve responses even further according to laboratory studies
PPP2R1A is an important predictive biomarker and possible treatment target for multiple cancer types, study found
HOUSTON, JULY 2, 2025 ― Patients with ovarian clear cell carcinoma (OCCC) whose tumors have specific mutations in the PPP2R1A gene were found ...
AI that thinks like us – and could help explain how we think
2025-07-02
Researchers at Helmholtz Munich have developed an artificial intelligence model that can simulate human behavior with remarkable accuracy. The language model, called Centaur, was trained on more than ten million decisions from psychological experiments – and makes decisions in ways that closely resemble those of real people. This opens new avenues for understanding human cognition and improving psychological theories.
For decades, psychology has aspired to explain the full complexity of human thought. Yet traditional models could either offer a transparent ...
The imitation game – why are some species better at fooling predators than others?
2025-07-02
Experts from the University of Nottingham have created life-size 3D-printed insect models to explore how some species trick predators into thinking they're more dangerous than they really are — and avoid being eaten as a result.
In the new study, published in Nature, a team of experts, led by Dr Tom Reader and Dr Christopher Taylor in the School of Life Sciences, used 3D printed models to investigate Batesian mimicry – a phenomenon where a harmless species evolves to resemble a harmful species, fooling ...
Gas leakage triggers wound healing in plants
2025-07-02
Scientists at the University of Helsinki discovered how plants heal their protective outer layer, the periderm. The diffusion of ethylene and oxygen through a wound triggers repair – a finding with potential implications for crop resilience, and food preservation.
All living organisms rely on protective barrier tissues to shield them from the environment. In plants, the periderm which forms the tough outer cork layer plays this role, helping to prevent water loss and block harmful microbes, for example in potato skin and tree bark. But what happens ...
Forging a novel therapeutic path for patients with Rett Syndrome using AI
2025-07-02
Forging a novel therapeutic path for patients with Rett Syndrome using AI
AI-enabled drug discovery approach identified potentially game-changing treatment which has been advanced from the lab bench to an FDA Orphan Drug Designation in record time
By Benjamin Boettner
(BOSTON) — Rett syndrome is a devastating rare genetic childhood disorder primarily affecting girls. Merely 1 out of 10,000 girls are born with it and much fewer boys. It is caused by mutations in the MeCP2 gene on the X chromosome, leading to a spectrum of cognitive and physical impairments, including ...
Global drought hotspots report catalogs severe suffering, economic damage in 2023-2025
2025-07-02
Fuelled by climate change and relentless pressure on land and water resources, some of the most widespread and damaging drought events in recorded history have taken place since 2023, according to a UN-backed report launched today.
Prepared by the U.S. National Drought Mitigation Center (NDMC) and the UN Convention to Combat Desertification (UNCCD), with support from the International Drought Resilience Alliance (IDRA), the report, "Drought Hotspots Around the World 2023-2025," provides a comprehensive account of how droughts compound poverty, ...
Study: To battle tip fatigue, businesses should make their service efforts visible
2025-07-02
PULLMAN, Wash. -- As customers face more and more prompts to add a tip to the bill in places where gratuities were not customary only a few years ago—and often before any service has been rendered—their attitudes toward the practice have turned sharply negative.
“Businesses should seriously consider whether they want to offer that tipping request,” said Ruiying Cai, an assistant professor in the WSU’s Carson College of Business and co-author of a new study published in the International Journal of Hospitality ...
This spongy material and the sun’s power remove salt from seawater
2025-07-02
Most of Earth’s water is in the oceans and too salty to drink. Desalination plants can make seawater drinkable, but they require large amounts of energy. Now, researchers reporting in ACS Energy Letters have developed a sponge-like material with long, microscopic air pockets that uses sunlight and a simple plastic cover to turn saltwater into freshwater. A proof-of-concept test outdoors successfully produced potable water in natural sunlight in a step toward low-energy, sustainable desalination.
This isn’t the first time scientists have created spongy materials that use sunlight as ...
Nearly 1 in 6 older adults take aspirin despite no history of heart disease
2025-07-02
Around 1 in 6 older adults take aspirin as their primary method of preventing cardiovascular disease – despite stricter guidelines that no longer always call for it, a study finds.
Almost one-quarter of those aspirin users started taking the medication without a physician recommendation and 8% had not discussed their use with any health care provider.
The results, published in the Journal of the American College of Cardiology, come from a survey of more than 2,500 adults aged ...